Clinical Trial Update: Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of brodalumab versus placebo and ustekinumab in moderate-to-severe plaque psoriasis has been terminated with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)
• brodalumab (brodalumab)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: TERMINATED | Results posted: 2020-01-03